These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 9521193)
21. Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group. Forsythe J Transplant Proc; 1999 Nov; 31(7A):69S-71S. PubMed ID: 10576049 [No Abstract] [Full Text] [Related]
22. Incidence of new-onset hypercholesterolemia in renal transplant patients treated with FK506 or cyclosporine. Satterthwaite R; Aswad S; Sunga V; Shidban H; Bogaard T; Asai P; Khetan U; Akra I; Mendez RG; Mendez R Transplantation; 1998 Feb; 65(3):446-9. PubMed ID: 9484771 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of neurotoxicity in pediatric renal transplant recipients treated with tacrolimus (FK506). Neu AM; Furth SL; Case BW; Wise B; Colombani PM; Fivush BA Clin Transplant; 1997 Oct; 11(5 Pt 1):412-4. PubMed ID: 9361932 [TBL] [Abstract][Full Text] [Related]
24. A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation. Gruessner RW; Burke GW; Stratta R; Sollinger H; Benedetti E; Marsh C; Stock P; Boudreaux JP; Martin M; Drangstveit MB; Sutherland DE; Gruessner A Transplantation; 1996 Jan; 61(2):261-73. PubMed ID: 8600635 [TBL] [Abstract][Full Text] [Related]
25. Posttransplant diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression. Paolillo JA; Boyle GJ; Law YM; Miller SA; Lawrence K; Wagner K; Pigula FA; Griffith BP; Webber SA Transplantation; 2001 Jan; 71(2):252-6. PubMed ID: 11213069 [TBL] [Abstract][Full Text] [Related]
26. Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study. Gnatta D; Keitel E; Heineck I; Cardoso BD; Rodrigues AP; Michel K; Garcia VD Transplant Proc; 2010 Mar; 42(2):475-8. PubMed ID: 20304169 [TBL] [Abstract][Full Text] [Related]
27. Renal interstitial fibrosis in children treated with FK506 for nephrotic syndrome. Morgan C; Sis B; Pinsk M; Yiu V Nephrol Dial Transplant; 2011 Sep; 26(9):2860-5. PubMed ID: 21303962 [TBL] [Abstract][Full Text] [Related]
28. Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Chakrabarti P; Wong HY; Scantlebury VP; Jordan ML; Vivas C; Ellis D; Lombardozzi-Lane S; Hakala TR; Fung JJ; Simmons RL; Starzl TE; Shapiro R Transplantation; 2000 Sep; 70(5):760-4. PubMed ID: 11003353 [TBL] [Abstract][Full Text] [Related]
29. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study. Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242 [TBL] [Abstract][Full Text] [Related]
30. Diabetes mellitus after renal transplantation under FK 506 (tacrolimus) as primary immunosuppression. Tanabe K; Koga S; Takahashi K; Sonda K; Tokumoto T; Babazono T; Yagisawa T; Toma H; Kawai T; Fuchinoue S; Teraoka S; Ota K Transplant Proc; 1996 Jun; 28(3):1304-5. PubMed ID: 8658670 [No Abstract] [Full Text] [Related]
31. Calcineurin inhibitors and Clostridium difficile infection in adult lung transplant recipients: the effect of cyclosporine versus tacrolimus. Lee JT; Whitson BA; Kelly RF; D'Cunha J; Dunitz JM; Hertz MI; Shumway SJ J Surg Res; 2013 Sep; 184(1):599-604. PubMed ID: 23566442 [TBL] [Abstract][Full Text] [Related]
32. Evaluating mechanisms of post-transplant diabetes mellitus. van Hooff JP; Christiaans MH; van Duijnhoven EM Nephrol Dial Transplant; 2004 Dec; 19 Suppl 6():vi8-vi12. PubMed ID: 15575024 [TBL] [Abstract][Full Text] [Related]
33. Tacrolimus (Pan Graf) as de novo therapy in renal transplant recipients in India. Guleria S; Kamboj M; Singh P; Sharma M; Pandey S; Chatterjee A; Dinda AK; Mahajan S; Gupta S; Bhowmik D; Agarwal SK; Tiwari SC; Dash SC Transplant Proc; 2006 Sep; 38(7):2029-31. PubMed ID: 16979989 [TBL] [Abstract][Full Text] [Related]
34. Insulin hyposecretion in nondiabetic, tacrolimus-treated renal transplant recipients more than 6 months posttransplantation. Ravindran VK; Moore RH; Dunseath G; Luzio SD; Owens DR; Baboolal K Transplantation; 2009 Jun; 87(12):1870-6. PubMed ID: 19543067 [TBL] [Abstract][Full Text] [Related]
35. Post-transplant lymphoproliferative disease in kidney transplant patients in the new immunosuppressive era. Ciancio G; Siquijor AP; Burke GW; Roth D; Cirocco R; Esquenazi V; Byrne GE; Miller J Clin Transplant; 1997 Jun; 11(3):243-9. PubMed ID: 9193850 [TBL] [Abstract][Full Text] [Related]
36. Tacrolimus in pediatric renal transplantation: a review. Shapiro R Pediatr Transplant; 1998 Nov; 2(4):270-6. PubMed ID: 10084728 [TBL] [Abstract][Full Text] [Related]